Search Results 2231-2240 of 18870 for Relapse
A Study of Using Lorvotuzumab Mertansine in Treating Younger Patients with Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma ...
Patients at high risk of relapse are eligible for InPACT-pelvis, where they are randomised to either: P. prophylactic PLND Q. no prophylactic PLND. Hypo ...
Mental health conditions can be harder to treat if you wait until symptoms get bad. Long-term maintenance treatment also may help prevent a relapse of symptoms.
... relapse-prevention, and rescue TMS. J Affect Disord. 2022 Jan 1; 296:79-88 Epub 2021 Sept 17. View PubMed; Nunez NA, Coombes BJ, Romo-Nava F, Bond DJ, Vande ...
... Relapsed or Metastatic Cancer Expressing NY-ESO-1 Rochester, MN. This is a Phase 1 multi-center study to evaluate the clinical safety and immune response of ...
Relapsed, refractory, or progressive disease, specifically: Solid tumors: Following at least 1 prior systemic therapy;; Classical HL: Following at least 2 ...
Root Cause of Multiple Myeloma Relapse Revealed. Dana Sparks. September 18, 2013. Cancer. Mayo Clinic Receives $8.8 Million Federal Grant for Metabolomics ...
Rochester, Minn. This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!